Carragelose Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

Carragelose General Information

Description

Developer of respiratory health medical device products intended for the prevention and treatment of viral respiratory conditions and allergen exposure. The company offers virus-blocking, allergen-blocking, and moisturizing nasal sprays, throat sprays, lozenges, and related mucosal protection products, enabling consumers and healthcare markets to reduce exposure to respiratory viruses and allergens while supporting respiratory wellness.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Korneuburg
  • Austria
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • Korneuburg
  • Austria

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Carragelose Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Carragelose‘s full profile, request access.

Request a free trial

Carragelose Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Carragelose Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Carragelose‘s full profile, request access.

Request a free trial

Carragelose FAQs

  • When was Carragelose founded?

    Carragelose was founded in 2007.

  • Where is Carragelose headquartered?

    Carragelose is headquartered in Korneuburg, Austria.

  • What is the size of Carragelose?

    Carragelose has 8 total employees.

  • What industry is Carragelose in?

    Carragelose’s primary industry is Drug Discovery.

  • Is Carragelose a private or public company?

    Carragelose is a Private company.

  • What is the current valuation of Carragelose?

    The current valuation of Carragelose is .

  • What is Carragelose’s current revenue?

    The current revenue for Carragelose is .

  • Who are Carragelose’s investors?

    Marinomed Biotech has invested in Carragelose.

  • When was Carragelose acquired?

    Carragelose was acquired on 28-Feb-2025.

  • Who acquired Carragelose?

    Carragelose was acquired by Unither Pharmaceuticals.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process